A Clinical Trial to Determine the Safety and Immunogenicity of Healthy Candidate (MERS-CoV) Vaccine ChAdOx1 MERS
Condition: Middle East Respiratory Syndrome Coronavirus Intervention: Biological: ChAdOx1 MERS Sponsors: King Abdullah International Medical Research Center; University of Oxford Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials